Home

PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Change in Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program PAR-21-337 (T32 Clinical Trial Not Allowed) NOT-TR-22-037 NCATS Oct 14, 2022 n/a UM1
Notice of Availability for Applicants to Verify Funding Tier Calculation for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-336 (K12), PAR-21-338 (T32), and PAR-21-337 (T32) NOT-TR-22-036 NCATS Oct 7, 2022 n/a UM1
Notice of Change in Eligibility for CTSA Program Funding Opportunities: PAR-21-336 (K12), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32) NOT-TR-22-035 NCATS Oct 7, 2022 n/a UM1
Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Eligibility NOT-TR-22-032 NCATS Jun 22, 2022 n/a UM1


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health